Gianmario Candore

1.2k total citations
18 papers, 515 citations indexed

About

Gianmario Candore is a scholar working on Toxicology, Pharmacology and Pediatrics, Perinatology and Child Health. According to data from OpenAlex, Gianmario Candore has authored 18 papers receiving a total of 515 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Toxicology, 6 papers in Pharmacology and 5 papers in Pediatrics, Perinatology and Child Health. Recurrent topics in Gianmario Candore's work include Pharmacovigilance and Adverse Drug Reactions (10 papers), Drug-Induced Adverse Reactions (6 papers) and Pharmaceutical studies and practices (5 papers). Gianmario Candore is often cited by papers focused on Pharmacovigilance and Adverse Drug Reactions (10 papers), Drug-Induced Adverse Reactions (6 papers) and Pharmaceutical studies and practices (5 papers). Gianmario Candore collaborates with scholars based in Netherlands, United Kingdom and Germany. Gianmario Candore's co-authors include Jim Slattery, A Wisniewski, Suzie Seabroke, Peter Arlett, Kristina Juhlin, Bharat Thakrar, Katrin Manlik, Xavier Kurz, G. Niklas Norén and Jean‐Michel Dogné and has published in prestigious journals such as Clinical Pharmacology & Therapeutics, British Journal of Clinical Pharmacology and Drug Safety.

In The Last Decade

Gianmario Candore

17 papers receiving 505 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Gianmario Candore Netherlands 9 326 106 103 100 89 18 515
Vaishali Patadia United States 9 347 1.1× 92 0.9× 95 0.9× 116 1.2× 69 0.8× 13 525
Kristina Juhlin Sweden 12 391 1.2× 134 1.3× 92 0.9× 150 1.5× 86 1.0× 17 554
Ola Caster Sweden 14 451 1.4× 141 1.3× 122 1.2× 159 1.6× 119 1.3× 26 832
Tomas Bergvall Sweden 10 236 0.7× 68 0.6× 64 0.6× 74 0.7× 57 0.6× 12 356
Alexandra Păcurariu Netherlands 12 184 0.6× 105 1.0× 136 1.3× 37 0.4× 96 1.1× 24 524
Johanna Strandell Sweden 9 249 0.8× 80 0.8× 66 0.6× 58 0.6× 99 1.1× 15 489
C. Kreft-Jaïs France 14 249 0.8× 166 1.6× 55 0.5× 59 0.6× 81 0.9× 38 774
Nancy Yuen United States 7 287 0.9× 104 1.0× 51 0.5× 102 1.0× 50 0.6× 9 534
Birgitta Grundmark Sweden 13 201 0.6× 89 0.8× 66 0.6× 37 0.4× 62 0.7× 18 593
Georgy Genov Netherlands 9 199 0.6× 59 0.6× 144 1.4× 26 0.3× 61 0.7× 14 389

Countries citing papers authored by Gianmario Candore

Since Specialization
Citations

This map shows the geographic impact of Gianmario Candore's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Gianmario Candore with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Gianmario Candore more than expected).

Fields of papers citing papers by Gianmario Candore

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Gianmario Candore. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Gianmario Candore. The network helps show where Gianmario Candore may publish in the future.

Co-authorship network of co-authors of Gianmario Candore

This figure shows the co-authorship network connecting the top 25 collaborators of Gianmario Candore. A scholar is included among the top collaborators of Gianmario Candore based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Gianmario Candore. Gianmario Candore is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

18 of 18 papers shown
1.
Candore, Gianmario, Claire Martin, Ashley Lloyd, et al.. (2025). FRAME: Framework for Real‐World Evidence Assessment to Mitigate Evidence Uncertainties for Efficacy/Effectiveness – An Evaluation of Regulatory and Health Technology Assessment Decision Making. Clinical Pharmacology & Therapeutics. 118(3). 649–661. 1 indexed citations
2.
3.
Gordillo‐Marañón, María, et al.. (2024). Lessons Learned on Observed-to-Expected Analysis Using Spontaneous Reports During Mass Vaccination. Drug Safety. 47(7). 607–615. 5 indexed citations
4.
Slattery, Jim, Chantal Quinten, Gianmario Candore, et al.. (2022). Ondansetron use in nausea and vomiting during pregnancy: A descriptive analysis of prescription patterns and patient characteristics in UK general practice. British Journal of Clinical Pharmacology. 88(10). 4526–4539. 5 indexed citations
5.
Candore, Gianmario, et al.. (2021). The Impact of Mandatory Reporting of Non-Serious Safety Reports to EudraVigilance on the Detection of Adverse Reactions. Drug Safety. 45(1). 83–95. 10 indexed citations
6.
Hedenmalm, Karin, et al.. (2021). Is There an Increased Risk of Hepatotoxicity with Metamizole? A Comparative Cohort Study in Incident Users. Drug Safety. 44(9). 973–985. 5 indexed citations
7.
Gini, Rosa, Miriam Sturkenboom, Janet Sultana, et al.. (2020). Different Strategies to Execute Multi‐Database Studies for Medicines Surveillance in Real‐World Setting: A Reflection on the European Model. Clinical Pharmacology & Therapeutics. 108(2). 228–235. 36 indexed citations
8.
Candore, Gianmario, Karin Hedenmalm, Jim Slattery, et al.. (2020). Can We Rely on Results From IQVIA Medical Research Data UK Converted to the Observational Medical Outcome Partnership Common Data Model?. Clinical Pharmacology & Therapeutics. 107(4). 915–925. 7 indexed citations
9.
Hedenmalm, Karin, Kevin Blake, Katherine Donegan, et al.. (2019). A European multicentre drug utilisation study of the impact of regulatory measures on prescribing of codeine for pain in children. Pharmacoepidemiology and Drug Safety. 28(8). 1086–1096. 14 indexed citations
10.
Slattery, Jim, et al.. (2018). EudraVigilance Medicines Safety Database: Publicly Accessible Data for Research and Public Health Protection. Drug Safety. 41(7). 665–675. 90 indexed citations
11.
Candore, Gianmario, Jim Slattery, François Houÿez, et al.. (2017). Patient Reporting in the EU: Analysis of EudraVigilance Data. Drug Safety. 40(7). 629–645. 59 indexed citations
12.
Candore, Gianmario, et al.. (2017). An algorithm to detect unexpected increases in frequency of reports of adverse events in EudraVigilance. Pharmacoepidemiology and Drug Safety. 27(1). 38–45. 8 indexed citations
13.
Wisniewski, A, Andrew Bate, Cédric Bousquet, et al.. (2016). Good Signal Detection Practices: Evidence from IMI PROTECT. Drug Safety. 39(6). 469–490. 106 indexed citations
14.
Seabroke, Suzie, Gianmario Candore, Kristina Juhlin, et al.. (2016). Performance of Stratified and Subgrouped Disproportionality Analyses in Spontaneous Databases. Drug Safety. 39(4). 355–364. 43 indexed citations
15.
Groot, Mark de, Gianmario Candore, Md Jamal Uddin, et al.. (2016). Case‐only designs for studying the association of antidepressants and hip or femur fracture. Pharmacoepidemiology and Drug Safety. 25(S1). 103–113. 11 indexed citations
16.
Uddin, Md Jamal, Rolf H. H. Groenwold, Anthonius de Boer, et al.. (2016). Instrumental variables analysis using multiple databases: an example of antidepressant use and risk of hip fracture. Pharmacoepidemiology and Drug Safety. 25(S1). 122–131. 6 indexed citations
17.
Candore, Gianmario, Kristina Juhlin, Katrin Manlik, et al.. (2015). Comparison of Statistical Signal Detection Methods Within and Across Spontaneous Reporting Databases. Drug Safety. 38(6). 577–587. 106 indexed citations
18.
Seabroke, Suzie, Kristina Juhlin, Gianmario Candore, et al.. (2014). Impact of Subgroup Analyses and Adjustment by Stratification on Safety Signal Detection for Individual Case Reports. Pharmacoepidemiology and Drug Safety. 23. 416–416.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Vaishali Patadia Breakdown of academic impact, for papers by Kristina Juhlin Breakdown of academic impact, for papers by Ola Caster Breakdown of academic impact, for papers by Tomas Bergvall Breakdown of academic impact, for papers by Alexandra Păcurariu Breakdown of academic impact, for papers by Johanna Strandell Breakdown of academic impact, for papers by C. Kreft-Jaïs Breakdown of academic impact, for papers by Nancy Yuen Breakdown of academic impact, for papers by Birgitta Grundmark Breakdown of academic impact, for papers by Georgy Genov
Rankless by CCL
2026